| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Omar Abdel-Sala. Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. Asian Pacific journal of tropical medicine. vol 9. issue 5. 2016-06-05. PMID:27261847. |
gastric acid inhibitory and gastric protective effects of cannabis and cannabinoids. |
2016-06-05 |
2023-08-13 |
Not clear |
| Omar Abdel-Sala. Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. Asian Pacific journal of tropical medicine. vol 9. issue 5. 2016-06-05. PMID:27261847. |
there is evidence that cb1 receptor stimulation with synthetic cannabinoids or cannabis sativa extracts rich in Δ(9)-tetrahydrocannabinol inhibit gastric acid secretion in humans and experimental animals. |
2016-06-05 |
2023-08-13 |
Not clear |
| Omar Abdel-Sala. Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids. Asian Pacific journal of tropical medicine. vol 9. issue 5. 2016-06-05. PMID:27261847. |
cannabis and/or cannabinoids protect the gastric mucosa against noxious challenge with non-steroidal anti-inflammatory drugs, ethanol as well as against stress-induced mucosal damage. |
2016-06-05 |
2023-08-13 |
Not clear |
| Xiaoshen Sun, Chaoying S Xu, Nisha Chadha, Allshine Chen, Ji Li. Marijuana for Glaucoma: A Recipe for Disaster or Treatment? The Yale journal of biology and medicine. vol 88. issue 3. 2016-06-01. PMID:26339209. |
the treatment of glaucoma based on the cannabis plant or drugs based on the cannabinoid molecule should be considered carefully before being prescribed. |
2016-06-01 |
2023-08-13 |
Not clear |
| Stephen P H Alexande. Therapeutic potential of cannabis-related drugs. Progress in neuro-psychopharmacology & biological psychiatry. vol 64. 2016-05-31. PMID:26216862. |
in this review, i will consider the dual nature of cannabis and cannabinoids. |
2016-05-31 |
2023-08-13 |
Not clear |
| Stephen P H Alexande. Therapeutic potential of cannabis-related drugs. Progress in neuro-psychopharmacology & biological psychiatry. vol 64. 2016-05-31. PMID:26216862. |
the duality arises from the potential and actuality of cannabinoids in the laboratory and clinic and the 'abuse' of cannabis outside the clinic. |
2016-05-31 |
2023-08-13 |
Not clear |
| Jason Sawler, Jake M Stout, Kyle M Gardner, Darryl Hudson, John Vidmar, Laura Butler, Jonathan E Page, Sean Myle. The Genetic Structure of Marijuana and Hemp. PloS one. vol 10. issue 8. 2016-05-18. PMID:26308334. |
drug types of cannabis (marijuana), which contain high amounts of the psychoactive cannabinoid Δ9-tetrahydrocannabinol (thc), are used for medical purposes and as a recreational drug. |
2016-05-18 |
2023-08-13 |
Not clear |
| Arnau Busquets-Garcia, Tifany Desprez, Mathilde Metna-Laurent, Luigi Bellocchio, Giovanni Marsicano, Edgar Soria-Gome. Dissecting the cannabinergic control of behavior: The where matters. BioEssays : news and reviews in molecular, cellular and developmental biology. vol 37. issue 11. 2016-05-17. PMID:26260530. |
the endocannabinoid system is the target of the main psychoactive component of the plant cannabis sativa, the Δ(9)-tetrahydrocannabinol (thc). |
2016-05-17 |
2023-08-13 |
Not clear |
| Edith Hochhauser, Eylon Lahat, Maya Sultan, Orit Pappo, Maayan Waldman, Yosef Sarne, Asher Shainberg, Mordechai Gutman, Michal Safran, Ziv Ben Ar. Ultra Low Dose Delta 9-Tetrahydrocannabinol Protects Mouse Liver from Ischemia Reperfusion Injury. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. vol 36. issue 5. 2016-05-16. PMID:26202357. |
delta-9-tetrahydrocannabinol (thc), a cannabinoid agonist, is the active components of marijuana. |
2016-05-16 |
2023-08-13 |
mouse |
| Jack A Prenderville, Áine M Kelly, Eric J Downe. The role of cannabinoids in adult neurogenesis. British journal of pharmacology. vol 172. issue 16. 2016-05-12. PMID:25951750. |
cannabinoids are a unique class of chemical compounds incorporating plant-derived cannabinoids (the active components of cannabis sativa), the endogenous cannabinoids and synthetic cannabinoid ligands, and these compounds are becoming increasingly recognized for their roles in neural developmental processes. |
2016-05-12 |
2023-08-13 |
Not clear |
| Udo Bonnet, Thorsten Borda, Norbert Scherbaum, Michael Speck. Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification (Part II): Psychiatric complaints and their relation to delta-9-tetrahydrocannabinol and its metabolites in serum. Drug and alcohol dependence. vol 155. 2016-05-09. PMID:26298553. |
to investigate the impact of inpatient detoxification treatment on psychiatric symptoms of chronic cannabis addicts and to analyze the influence of serum cannabinoid levels on the severity of these symptoms. |
2016-05-09 |
2023-08-13 |
Not clear |
| Kamil Detyniecki, Lawrence Hirsc. Marijuana Use in Epilepsy: The Myth and the Reality. Current neurology and neuroscience reports. vol 15. issue 10. 2016-05-09. PMID:26299273. |
first, we review the preclinical and human evidences for the anticonvulsant properties of the different cannabinoids, mainly tetrahydrocannabinol (thc) and cannabidiol (cbd). |
2016-05-09 |
2023-08-13 |
human |
| Musa Basser Sami, Eugenii A Rabiner, Sagnik Bhattacharyy. Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 25. issue 8. 2016-05-06. PMID:26068702. |
we aimed to review all studies conducted in man, with any reported neurochemical outcomes related to the dopamine system after cannabis, cannabinoid or endocannabinoid administration or use. |
2016-05-06 |
2023-08-13 |
human |
| Nathalie A Desrosiers, Karl B Scheidweiler, Marilyn A Huesti. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug testing and analysis. vol 7. issue 8. 2016-05-04. PMID:25428610. |
Δ(9) -tetrahydrocannabinol (thc) is the most commonly analyzed cannabinoid in oral fluid (of); however, its metabolite 11-nor-9-carboxy-thc (thccooh) offers the advantage of documenting active consumption, as it is not detected in cannabis smoke. |
2016-05-04 |
2023-08-13 |
Not clear |
| Nathalie A Desrosiers, Karl B Scheidweiler, Marilyn A Huesti. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug testing and analysis. vol 7. issue 8. 2016-05-04. PMID:25428610. |
presence of minor cannabinoids like cannabidiol and cannabinol offer the advantage of identifying recent cannabis intake. |
2016-05-04 |
2023-08-13 |
Not clear |
| Nathalie A Desrosiers, Karl B Scheidweiler, Marilyn A Huesti. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug testing and analysis. vol 7. issue 8. 2016-05-04. PMID:25428610. |
we developed and validated a sensitive and specific liquid chromatography-tandem mass spectrometry (lc-ms/ms) method for thc, its metabolites, 11-hydroxy-thc and thccooh quantification, and other natural cannabinoids including tetrahydrocannabivarin (thcv), cannabidiol (cbd), and cannabigerol (cbg) in 1 ml of collected with the quantisal device. |
2016-05-04 |
2023-08-13 |
Not clear |
| Katherine A Belendiuk, Kimberly A Babson, Ryan Vandrey, Marcel O Bonn-Mille. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addictive behaviors. vol 50. 2016-05-04. PMID:26151582. |
cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. |
2016-05-04 |
2023-08-13 |
Not clear |
| Katherine A Belendiuk, Kimberly A Babson, Ryan Vandrey, Marcel O Bonn-Mille. Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users. Addictive behaviors. vol 50. 2016-05-04. PMID:26151582. |
little research has documented preferences for particular cannabis types or cannabinoid concentrations as a function of use for sleep disturbances. |
2016-05-04 |
2023-08-13 |
Not clear |
| Susan Fung, Allison E Cherry, Cong Xu, Nephi Stell. Alkylindole-sensitive receptors modulate microglial cell migration and proliferation. Glia. vol 63. issue 10. 2016-05-03. PMID:25914169. |
cannabinoids, including the active component of the cannabis plant, tetrahydrocannabinol (thc), and the synthetic alkylindole (ai) compound, win55212-2 (win-2), activate two molecularly identified gpcrs: cb1 and cb2 . |
2016-05-03 |
2023-08-13 |
mouse |
| Timothy E Albertson, James A Chenoweth, Daniel K Colby, Mark E Sutte. The Changing Drug Culture: Medical and Recreational Marijuana. FP essentials. vol 441. 2016-05-03. PMID:26881768. |
the major psychoactive compounds in marijuana (cannabis) are cannabinoids, the most significant of which is delta-9-tetrahydrocannabinol. |
2016-05-03 |
2023-08-13 |
Not clear |